Medicine recalls
|
| |
| Canada: Ventolin Diskus: One lot recalled as inhalers may not deliver the intended dose |
| |
Health Canada is advising Canadians that GlaxoSmithKline Inc. is voluntarily recalling one lot of Ventolin Diskus inhalers (200mcg salbutamol per blister, 60 dose, lot 786G, expiry 05 2019) because the products may not deliver the intended dose. Individuals who do not receive the intended dose may not be aware that the dose was not delivered.
If individuals do not receive the therapeutic dose as expected, their symptoms (cough, wheeze, breathlessness or tight chest) may get worse over time and they can suffer serious health consequences, including a potentially life-threatening asthma attack.
GlaxoSmithKline Inc. has advised Health Canada that it is conducting the recall after identifying a manufacturing issue with the affected lot that may result in a small number of devices not delivering the full number of doses.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../66016a-eng.php
In Hong Kong, Ventolin Accuhaler 200mcg (HK-42389) is a pharmaceutical product registered by GlaxoSmithKline Limited (GSK), and is a prescription-only medicine. As confirmed with GSK, the affected batch has not been imported into Hong Kong.
Ends/Tuesday, Feb 20, 2018
Issued at HKT 16:00
|
| |
|
